Cytek Biosciences Inc.

5.75
0.06 (1.05%)
At close: Jan 24, 2025, 3:59 PM
5.74
-0.09%
After-hours Jan 24, 2025, 04:00 PM EST
1.05%
Bid 5.58
Market Cap 740.02M
Revenue (ttm) 197.84M
Net Income (ttm) -9.99M
EPS (ttm) -0.08
PE Ratio (ttm) -71.81
Forward PE 117.33
Analyst Buy
Ask 5.88
Volume 399,547
Avg. Volume (20D) 753,735
Open 5.66
Previous Close 5.69
Day's Range 5.65 - 5.82
52-Week Range 4.66 - 9.33
Beta 1.32

About CTKB

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full sp...

Sector Healthcare
IPO Date Jul 23, 2021
Employees 645
Stock Exchange NASDAQ
Ticker Symbol CTKB

Analyst Forecast

According to 2 analyst ratings, the average rating for CTKB stock is "Buy." The 12-month stock price forecast is $9.25, which is an increase of 61.01% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Cytek Biosciences Inc. is scheduled to release its earnings on Feb 26, 2025, during market hours.
Analysts project revenue of $60.89M, reflecting a 4.56% YoY growth and earnings per share of 0.11, making a 175.00% increase YoY.
2 months ago
+36.03%
Cytek Biosciences shares are trading higher after ... Unlock content with Pro Subscription
5 months ago
-9.43%
Cytek Biosciences shares are trading lower after the company reported worse-than-expected Q2 financial results.